Stock listing
Damora Therapeutics, Inc.
Selected listing: DMRA · BOATS · USD · US
Damora Therapeutics, Inc. (BOATS:DMRA), Health Technology. Latest release Oct 5, 2026: Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing…
- Ticker
- BOATS:DMRA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
About Damora Therapeutics, Inc.
Damora Therapeutics, Inc. is a public company traded under the ticker DMRA in the American market. Its commitment to advancing healthcare is reflected in its strategic initiatives and research efforts.
Latest news from Damora Therapeutics, Inc.
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
October 5, 2026
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 10, 2026
Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis
August 5, 2026
Damora Announces Redomestication from Delaware to Cayman Islands
July 17, 2026
Research Damora Therapeutics, Inc.
Damora Therapeutics, Inc. company profile
View the public company page for Damora Therapeutics, Inc. on 6ix.
Damora Therapeutics, Inc. news
Read company news and market updates connected to Damora Therapeutics, Inc..
Damora Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Damora Therapeutics, Inc..